{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T03:12:18Z","timestamp":1776309138825,"version":"3.50.1"},"reference-count":26,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2013,5,13]],"date-time":"2013-05-13T00:00:00Z","timestamp":1368403200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0062034","type":"journal-article","created":{"date-parts":[[2013,5,13]],"date-time":"2013-05-13T21:06:30Z","timestamp":1368479190000},"page":"e62034","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":36,"title":["Diagnosis and Interim Treatment Outcomes from the First Cohort of Multidrug-Resistant Tuberculosis Patients in Tanzania"],"prefix":"10.1371","volume":"8","author":[{"given":"Stellah G.","family":"Mpagama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott K.","family":"Heysell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nora D.","family":"Ndusilo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Happiness H.","family":"Kumburu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isack A.","family":"Lekule","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riziki M.","family":"Kisonga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean","family":"Gratz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin J.","family":"Boeree","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric R.","family":"Houpt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gibson S.","family":"Kibiki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2013,5,13]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1016\/S0140-6736(10)60410-2","article-title":"Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis","volume":"375","author":"NR Gandhi","year":"2010","journal-title":"The Lancet"},{"key":"ref2","unstructured":"World Health Organization (2010) Global tuberculosis control. Geneva, World Health Organization."},{"key":"ref3","unstructured":"World Health Organization (2011) Guidelines for the programmatic management of drug-resistan<italic>t<\/italic> tuberculosis, Update. Geneva, World Health Organization."},{"key":"ref4","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/QCO.0b013e3283210020","article-title":"Multidrug-resistant and extensively drug-resistant tuberculosis: consequences for the global HIV community","volume":"22","author":"S Shenoi","year":"2009","journal-title":"Curr Opin Infect Dis"},{"key":"ref5","first-page":"967","article-title":"National anti-tuberculosis drug resistance study in Tanzania","volume":"14","author":"TM Chonde","year":"2010","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref6","unstructured":"Ministry of Health Tanzania. Health Sector Strategic Plan III (2009\u20132015)."},{"key":"ref7","doi-asserted-by":"crossref","first-page":"e15841","DOI":"10.1371\/journal.pone.0015841","article-title":"Culture conversion among HIV co-infected multidrug-resistant tuberculosis patients in Tugela Ferry, South Africa","volume":"6","author":"JC Brust","year":"2011","journal-title":"PLoS ONE"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1056\/NEJMoa0808427","article-title":"The diarylquinoline TMC207 for multidrug-resistant tuberculosis","volume":"360","author":"AH Diacon","year":"2009","journal-title":"N Engl J Med"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"e7186","DOI":"10.1371\/journal.pone.0007186","article-title":"Early Outcomes of MDR-TB Treatment in a High HIV-Prevalence Setting in Southern Africa","volume":"4","author":"KJ Seung","year":"2009","journal-title":"PLoS ONE"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"650","DOI":"10.7326\/0003-4819-144-9-200605020-00008","article-title":"Time to sputum culture conversion in multidrug-resistant tuberculosis: predictors and relationship to treatment outcome","volume":"144","author":"TH Holtz","year":"2006","journal-title":"Ann Intern Med"},{"key":"ref11","unstructured":"Ministry of Health Tanzania (2010) Operational Guideline for the Management of Drug Resistant TB in Tanzania."},{"key":"ref12","first-page":"1382","article-title":"Adverse events in the treatment of multidrug-resistant tuberculosis: results from the DOTS-Plus initiative","volume":"8","author":"E Nathanson","year":"2004","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/j.1365-2249.2007.03330.x","article-title":"Bronchoalveolar neutrophils, interferon gamma-inducible protein 10 and interleukin-7 in AIDS-associated tuberculosis","volume":"148","author":"GS Kibiki","year":"2007","journal-title":"Clin Exp Immunol"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Brust JCM, Shah NS, Scott M, Chaiyachati K, Lygizos M, <etal>et al<\/etal>.. (2012) Integrated, home-based treatment for MDR-TB and HIV in rural South Africa: an alternate model of care. Int J Tuberc Lung Dis 16(8), 998\u20131004.","DOI":"10.5588\/ijtld.11.0713"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Loveday M, Wallengren K, Voce A, Margot B, Reddy T, <etal>et al<\/etal>.. (2012) Comparing early treatment outcomes of MDR-TB in decentralised and centralised settings in KwaZulu-Natal, South Africa. The International J Tuberc and Lung Dis 16(2), 209\u2013215.","DOI":"10.5588\/ijtld.11.0401"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"e46943","DOI":"10.1371\/journal.pone.0046943","article-title":"Outcomes of multidrug-resistant tuberculosis treatment with early initiation of antiretroviral therapy for HIV co-infected patients in Lesotho","volume":"7","author":"H Satti","year":"2012","journal-title":"PLoS ONE"},{"key":"ref17","first-page":"15","article-title":"Outcome of multi-drug resistant tuberculosis cases treated by individualized regimens at a tertiary level clinic","volume":"55","author":"VK Dhingra","year":"2008","journal-title":"Indian J Tuberc"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1128\/AAC.47.9.2971-2973.2003","article-title":"Discordant resistance to kanamycin and amikacin in drug-resistant Mycobacterium tuberculosis","volume":"47","author":"A Kruuner","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"5819","DOI":"10.1128\/AAC.05561-11","article-title":"Plasma drug activity assay for treatment optimization in tuberculosis patients","volume":"55","author":"SK Heysell","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1183\/09031936.06.00125705","article-title":"Outcome of pulmonary multidrug-resistant tuberculosis: a 6-yr follow-up study","volume":"28","author":"CY Chiang","year":"2006","journal-title":"Eur Respir J"},{"key":"ref21","first-page":"648","article-title":"Occurrence of serious adverse effects in patients receiving community-based therapy for multidrug-resistant tuberculosis","volume":"5","author":"JJ Furin","year":"2001","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref22","first-page":"1382","article-title":"Adverse events in the treatment of multidrug-resistant tuberculosis: results from the DOTS-Plus initiative","volume":"8","author":"E Nathanson","year":"2004","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref23","first-page":"1373","article-title":"Side effects associated with the treatment of multidrug-resistant tuberculosis","volume":"9","author":"T Torun","year":"2005","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref24","unstructured":"Francis J Curry National Tuberculosis Center and California Department of Health (2008) Drug Resistant Tuberculosis A Survival Guide for Clinicians. 86\u201387."},{"key":"ref25","first-page":"1244","article-title":"Extensively drug-resistant tuberculosis in children with human immunodeficiency virus in rural South Africa","volume":"14","author":"TA Thomas","year":"2010","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S1473-3099(10)70139-0","article-title":"Best drug treatment for multidrug-resistant and extensively drug-resistant tuberculosis","volume":"10","author":"JA Caminero","year":"2010","journal-title":"The Lancet Infectious Diseases"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0062034","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T23:24:13Z","timestamp":1540337053000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0062034"}},"subtitle":[],"editor":[{"given":"Katharina","family":"Kranzer","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2013,5,13]]},"references-count":26,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2013,5,13]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0062034","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,13]]}}}